Knightscope stock: Signals moves from reveal to live operations
NuCana stock: Edison highlights ProTide oncology focus
PLAYSTUDIOS stock regains Nasdaq compliance after reverse split
Palantir's Blockbuster Quarter Collides With a Stalling Order Book
SpaceX's Cash Clock: Why a $175 Billion Forecast Still Leaves a Six-Year Gap
Neurocrine Biosciences stock: Q3 revenue jumps 41%, outlook raised
MaxLinear stock trades at 51.14 euros late Wednesday
Andamanda Phuket: A Must-Visit Water Park for Family Holiday
OceanFirst Financial stock: Flushing integration reaches next phase
Oxbridge Re stock links tokenized reinsurance with AI infrastructure
Provident Financial Services stock posts record revenue despite charges
LENSAR stock faces a scheduled Q3 results release next week
PROCEPT BioRobotics stock posts 18% Q3 revenue growth
Kearny Financial stock posts 40% earnings gain in fiscal Q1
Monolithic Power stock hits record revenue above USD 1 billion
NEXGEL stock regains Nasdaq compliance after bid-price breach
Nomad Power Solutions stock targets larger battery systems for 2027
Oncolytics Biotech stock: GOBLET findings strengthen pelareorep case
Mercedes-Benz Rallies Twice in Two Days, but the Profit Story Still Needs Proving
Peoples Bancorp stock reports Q3 profit as merger plans advance
MKS stock posts record revenue and raises fourth-quarter outlook
Purple Innovation stock cuts EBITDA outlook after Q3 revenue drop
PMV Pharmaceuticals stock: PYNNACLE results set for ENA presentation
Qfin Holdings stock faces fresh securities lawsuit deadline
Midland States Bancorp stock sets November dividend dates
MicroVision stock: FieldAI expands lidar collaboration
PTC stock in focus after fourth-quarter results
Pacira BioSciences stock: Viatris starts USD 36.50 tender offer
Organogenesis stock at 0.78 euros before third-quarter results
ServiceNow's NBA Win Lands in the Same Week Its Forward Book Gets Graded
SK Hynix's US Ambitions Run Into a Dalian Paper Jam
Progress Software stock draws fresh institutional interest from Prescott Group
Lexicon Pharmaceuticals stock faces Q3 results before market open